Watch on Demand! Advance Scientific Innovation with M Lab™ Collaboration Centers Panel Discussion

51451_2023_EB_Symposium_1200x650_Speaker_Final

We invite you to the 4th Annual Biotech Start-up Symposium, a free, two-day event to help Biotech Start-ups navigate their path to commercialization. This Symposium features industry experts who present and discuss various aspects of emerging technologies and the latest trends in their fields.

On November 14th, Day 1, you won’t want to miss the panel discussion lead by Rebecca Dhrimaj on Advance Scientific Innovation with M Lab™ Collaboration Centers

Here is an overview of what will be discussed:

In this dynamic panel discussion, we will explore real-world examples of how startups engage with our global network of 300+ technical experts to advance their molecule to market. By attending this session you will learn how to engage with our network of 120 in-house certified trainers, in-person or virtually, to enhance your technical skill set. As part of this session, an exciting surprise will be shared with the audience.

Watch on Demand!

Director, Manufacturing Sciences & Technology

Adam Sokolnicki is the Director of the MSAT-Downstream group of Biomanufacturing Engineers in North America who help end-users establish robust, reliable, and reproducible downstream processes in their biopharmaceutical manufacturing operations. Adam is keenly interested in next-generation manufacturing strategies and how our products can be used for intensified and continuous bioprocesses. He joined our company in 2009 after spending 5 years at the biotech startup Altus Pharmaceuticals conducting process development, process engineering, and technology transfer for phase III and commercial manufacturing of biologics. He has over 18 years of industry experience including process development and optimization of biopharmaceutical manufacturing. He obtained a BS and a MS in chemical engineering from Tufts University.

Director, Manufacturing Sciences & Technology

Andrew Clutterbuck is the Director of our companies Manufacturing Sciences & Technology (MSAT) group for Europe, Middle East & Africa regions. With 22 years biomanufacturing experience from process development through to cGMP manufacturing, Andrew joined our company in 2011 after working for contract manufacturing organisations in the UK in several development and manufacturing roles developing, scaling and manufacturing biopharmaceuticals. Andrew holds a degree in Molecular & Cellular Biology from the University of Huddersfield, UK.

Head of Technical & Scientific Solutions LATAM

As the Head of Technical & Scientific Solutions for Latin America, Oscar leads a team of consulting and process development scientists who are passionate about helping pharma and biopharma companies solve their toughest challenges and adopt innovative technologies.

Oscar’s formal background is in biology, and he holds a degree in Biotechnology. He also completed his postgraduate studies in Strategic Marketing, Business and Finance.

Oscar is based in Buenos Aires and has been leading high performing teams since 2005.

Head of Technical and Scientific Solutions APAC

Yanglin Mok is a Director at our company with 17 years of experience in biotech industry. She has held several leadership positions including Business development and the Manufacturing Science and Technology within APAC. She has diverse experience leading global programs and cross functional teams and is currently the Head of Technical and Scientific Solutions organization for APAC excluding China.

Yanglin has a Masters in Business Administration from the National University of Singapore and University of California, Los Angeles and a degree in Chemical Engineering from the University of Melbourne, Australia. She is an author of 3 papers published in international journals and has presented in conferences on topics relating to best practices in bioprocessing.

Director, Technical & Scientific Solutions

Bin Wang is the Director of Technical & Scientific Solutions Group at our company in China, wherein he leads a strong globally networked group including Process Development, MSAT, Technical Operation, Tech Service and Field Service teams. This group is the technical function of our company and provides comprehensive solution covering process development from upstream cell culture to downstream purification, FCD & process engineering, technic inquiry & consultation, HW qualification & implementation, and technical collaborations. Before this position, he used to lead Asia MSAT team to support PD, scaling up and implementation activities for Asia biopharmaceutical companies. Between 2016 to 2017, Bin Wang worked in at our companies MSAT team and provided PD and scaling-up support for biopharmaceutical companies in North American.

Bin Wang has more than 20 years’ experience in Biopharmaceutical industry in both China and USA. Before joining our company, Bin Wang worked in FOSUN PHARMA, Asia United mAb Medical and BMS as PD manager, mAb pilot facility manager and GMP compliance supervisor. He is the lecturer of Separation course at East China University of Science & Technology, used to be the lecturer of NMPA Institute of Executive Development, Peking University’s IPEM program, and Taiwan ITRI Pharmaceutical program.

Marketing Manager

Rebecca Dhrimaj is a purpose-driven leader with a passion for uniting diverse communities to shape an environment where teams work together to ignite positive change. Rebecca has spent the last 16 years impacting life and health with science by driving strategy and execution of marketing and thought leadership programs in the life sciences industry.

Rebecca is a Fulbright alumnus, holds a Master of Science in International Business and Marketing from the Universiteit Maastricht, and a bachelor’s degree in French for International Trade and Economics from Indiana University of Pennsylvania.

 

Related Posts

Hiring Challenges in Bioprocessing for Start-ups

Creating Bottlenecks in Europe; Opportunities for Production Staff BioPlan Associates, Inc. Hiring of bioprocessing professionals has remained a…

When to sprint and when to breathe in the race from lab to clinic – 5 critical steps to success

As an early-stage or small-sized biotech company, you need to move fast and be nimble.  Success is measured…

Starting your journey into manufacturing – choosing a cell line development provider

One of the biggest decisions which any company developing biological medicines makes is to move forward to the manufacture of their product. …

A Streamlined Approach to Analytical Method Development and Implementation

The development and implementation of analytical methods are essential for success at all phases of a molecule’s journey,…

Scroll to Top